Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,499,317
+$3,774,154 QoQ
Shares Held
173,945
+50.4% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 314 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. XENE ranks #27 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in XENE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,499,317 | 173,945 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $6,725,163 | 115,652 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,825,950 | 152,297 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,626,122 | 115,221 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,523,188 | 112,562 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,211,347 | 65,912 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,333,183 | 59,520 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,380,152 | 60,456 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,303,021 | 59,067 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,645,723 | 61,457 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,690,963 | 58,423 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,037,063 | 59,633 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,255,830 | 58,593 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $141,227 | 3,946 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $44,279 | 1,123 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,050 | 500 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||